Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,392 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Paclitaxel-carboplatin and bevacizumab combination with maintenance bevacizumab therapy for metastatic, recurrent, and persistent uterine cervical cancer: An open-label multicenter phase II trial (JGOG1079).
Tanigawa T, Takeshima N, Ishikawa H, Nishio S, Usami T, Yamawaki T, Oishi T, Ihira K, Kato H, Goto M, Saito M, Taira Y, Yokoyama M, Shoji T, Kondo E, Mori A, Yokoi T, Iwasa-Inoue N, Hirashima Y, Nagasawa T, Takenaka M, Mikami M, Sugiyama T, Enomoto T. Tanigawa T, et al. Among authors: nagasawa t. Gynecol Oncol. 2022 Jun;165(3):413-419. doi: 10.1016/j.ygyno.2022.04.011. Epub 2022 Apr 27. Gynecol Oncol. 2022. PMID: 35487773 Clinical Trial.
[Chemotherapy for ovarian cancer].
Sugiyama T, Nagasawa T, Nakayama I. Sugiyama T, et al. Among authors: nagasawa t. Nihon Rinsho. 2012 Jun;70 Suppl 4:594-600. Nihon Rinsho. 2012. PMID: 23156316 Japanese. No abstract available.
A recurrent ovarian cancer patient with a history of nine prior chemotherapy regimens who was safely treated with weekly paclitaxel plus bevacizumab and achieved a complete response: a case report.
Takatori E, Shoji T, Nagasawa T, Takeuchi S, Hosoyachi A, Sugiyama T. Takatori E, et al. Among authors: nagasawa t. Onco Targets Ther. 2015 Aug 11;8:2097-100. doi: 10.2147/OTT.S80143. eCollection 2015. Onco Targets Ther. 2015. PMID: 26316778 Free PMC article.
Phase II clinical study of neoadjuvant chemotherapy with CDDP/CPT-11 regimen in combination with radical hysterectomy for cervical cancer with a bulky mass.
Shoji T, Takatori E, Furutake Y, Takada A, Nagasawa T, Omi H, Kagabu M, Honda T, Miura F, Takeuchi S, Kumagai S, Yoshizaki A, Sato A, Sugiyama T. Shoji T, et al. Among authors: nagasawa t. Int J Clin Oncol. 2016 Dec;21(6):1120-1127. doi: 10.1007/s10147-016-1008-7. Epub 2016 Jun 24. Int J Clin Oncol. 2016. PMID: 27342833 Free PMC article. Clinical Trial.
A retrospective study of neoadjuvant chemotherapy plus radical hysterectomy versus radical hysterectomy alone in patients with stage II cervical squamous cell carcinoma presenting as a bulky mass.
Takatori E, Shoji T, Takada A, Nagasawa T, Omi H, Kagabu M, Honda T, Miura F, Takeuchi S, Sugiyama T. Takatori E, et al. Among authors: nagasawa t. Onco Targets Ther. 2016 Sep 13;9:5651-5657. doi: 10.2147/OTT.S101146. eCollection 2016. Onco Targets Ther. 2016. PMID: 27695343 Free PMC article.
Phase 1 study of veliparib with carboplatin and weekly paclitaxel in Japanese patients with newly diagnosed ovarian cancer.
Nishio S, Takekuma M, Takeuchi S, Kawano K, Tsuda N, Tasaki K, Takahashi N, Abe M, Tanaka A, Nagasawa T, Shoji T, Xiong H, Nuthalapati S, Leahy T, Hashiba H, Kiriyama T, Komarnitsky P, Hirashima Y, Ushijima K. Nishio S, et al. Among authors: nagasawa t. Cancer Sci. 2017 Nov;108(11):2213-2220. doi: 10.1111/cas.13381. Epub 2017 Sep 18. Cancer Sci. 2017. PMID: 28837250 Free PMC article. Clinical Trial.
1,392 results